ASZ1 and infection: HEV ORF3 equipped with the myotropic adeno-associated virus vector (AAVMYO3) induced dose-dependent ORF3 antibodies in mice and the serum immunized by ORF3 inhibited infection by enveloped HEV in vivo by 50% compared with that of the control (Maurer et al., 2022).